Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Uncover the best no annual fee rewards card for your needs. Our guide helps you navigate options to enhance your spending benefits.
23,410 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Georgia and Tether announce a plan to deploy GEL₮, a stablecoin tied to the Georgian lari, designed to ride private p...
Box Inc is set to release Q1 results after the bell, with investors watching AI monetization progress and insider sel...
When a stock suddenly pops, traders buzz and headlines flare. This guide breaks down why those moves happen, how to t...
Hyperliquid (HYPE) faces a hyperliquid (hype) price down pullback after peaking near $65, with the token hovering aro...
Bitcoin sits at a crossroads as whales accumulate and policy debates heat up. This piece breaks down how many BTC cou...
Space-focused equities moved in contrasting directions after a Blue Origin test setback, with spacemobile plunges 17%...
Gold resumes its ascent in 2026, with three ETFs offering distinct risk paths to access the metal. GLD, GLDM, and GDX...
Solana faces a steep climb to overtake Ethereum by 2028 as the market-gap and capital flows test the premise. Analyst...
Mortgage application fraud risk fell 9.3% year over year in Q1 2026, signaling a return to long-run norms as refinanc...
State investigators are scrutinizing FIFA ticketing as dynamic pricing drives eye-popping costs and questions about s...
Cathie Wood's Ark Invest has been quietly loading up on Nvidia this week. Here are three solid reasons why her buying...